Paper Details

  1. Home
  2. Paper Details

Comparison of inhaled albuterol powder and aerosol in asthma.

Author: BronskyE, BucholtzG A, BusseW W, ChervinskyP, CondemiJ, GhafouriM A, HudsonL, LakshminarayanS, LockeyR, ReeseM E

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the effectiveness and safety of inhaled albuterol in powder and aerosol forms. Both forms were equally effective and safe for patients with chronic obstructive airway disease.
Paper Details　
Original Abstract of the Article :
In this multicenter, randomized, double-blind study comparing the efficacy and safety of aerosolized albuterol with the dry powder formulation, 231 patients with chronic reversible obstructive airway disease were randomly allocated to receive either placebo albuterol aerosol followed immediately by ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0091-6749(87)90205-3

データ提供：米国国立医学図書館（NLM）

Two Roads Lead to Relief: Comparing Inhaled Albuterol Delivery Methods

Asthma, a chronic respiratory disease, can be a challenging journey through a desert of shortness of breath. This study investigates two methods of delivering the medication albuterol: aerosolized albuterol and dry powder albuterol. The researchers wanted to determine if these two delivery systems are equally effective and safe for patients with asthma. They found that both forms of albuterol were equally effective in improving lung function, relieving symptoms, and had a similar safety profile. This valuable comparison provides a roadmap for healthcare providers to choose the best delivery method for each individual patient, allowing them to better navigate the desert of asthma management.

Choosing the Right Path: Albuterol Delivery Methods for Asthma Management

This study sheds light on the importance of individualized treatment for asthma. The fact that both aerosolized and dry powder albuterol were found to be equally effective highlights the need for doctors to consider factors such as patient preference and individual needs when choosing the best delivery method. This can lead to improved patient adherence and better control over asthma symptoms.

Breathing Easy: The Choice is Yours

This study offers a reassuring message for individuals managing asthma. It shows that there are different ways to take albuterol, allowing patients to choose the method that works best for them, making asthma management a more manageable and personalized journey.

Dr. Camel's Conclusion

This study is a welcome oasis in the desert of asthma research, providing valuable information for patients and healthcare providers. Both delivery methods were found to be equally effective, ensuring that individuals with asthma have choices in their treatment, allowing them to breathe easier and find the path to optimal management.

Date :
  1. Date Completed 1987-06-15
  2. Date Revised 2019-07-23
Further Info :

Pubmed ID

3553277

DOI: Digital Object Identifier

10.1016/0091-6749(87)90205-3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.